A double‐blind study of adjunctive carbamazepine versus placebo on excited states of schizophrenic and schizoaffective disorders

Acta Psychiatrica Scandinavica

Volumn 80, Issue 3, 1989, Pages 250-259

  Okuma, T ^a   Yamashita, I ^b   Takahashi, R ^c   Itoh, H ^d   Otsuki, S ^e   Watanabe, S ^f   Sarai, K ^g   Hazama, H ^h   Inanaga, K ⁱ  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^f KAWASAKI MEDICAL SCHOOL   (Japan)

^g HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^h TOTTORI UNIVERSITY   (Japan)

ⁱ KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

carbamazepine; schizoaffective disorder; schizophrenia

Indexed keywords

CARBAMAZEPINE; NEUROLEPTIC AGENT; PLACEBO;

ADULT; AGGRESSION; HUMAN; LASSITUDE; MAJOR CLINICAL STUDY; ORTHOSTATIC HYPOTENSION; SCHIZOIDISM; SCHIZOPHRENIA; SOMNOLENCE; UNSTEADINESS;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; CARBAMAZEPINE; CLINICAL TRIALS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; MALE; MIDDLE AGE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0024462902     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1989.tb01334.x     Document Type: Article

References (27)

1. The use of carbamazepine (Tegretol) in the control of manic‐depressive psychosis and other manic‐depressive states
2. Anti‐manic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis. A preliminary report
3. Comparison of the anti‐manic efficacy of carbamazepine and chlorpromazine. A double‐blind controlled study
4. A preliminary double‐blind study on the efficacy of carbamazepine in prophylaxis of manic‐depressive illness
5. Therapeutic and prophylactic effects of carbamazepine in bipolar disorders
6. Therapeutic and prophylactic efficacy of carbamazepine in manic depressive psychosis
7. Carbamazepine in manic‐depressive illness, a new treatment
8. Carbamazepine versus lilhium in mania ‐ a double‐blind study
9. The comparative efficacy and safety of carbamazepine versus lithium ‐ a randomized, double‐blind 3‐year trial in 83 patients
10. Psychotropic effect of carbamazepine (Tegrelol)
11. Carbamazepine in treatment of violent schizophrenics
12. Carbamazepine in violent schizophrenics
13. Carbamazepine in psychiatric patient
14. Carbamazepine in alcohol withdrawal syndromes and schizophrenic psychoses
15. Carbamazepine to violent psychiatric patients
16. The effect of carbamazepine on haloperidol plasma neuroleptic level
17. Open clinical trial of carbamazepine in chronic schizophrenic inpatients
18. Car b amaze pine and haloperidol vs. placebo and haloperidol in excited psychoses
19. Carbamazepine as adjunct of antipsychotic therapy
20. Efficacy of adjunaive carbamazepine in the treatment of chronic schizophrenia
21. Therapeutic effect or carbamazepine in mania, atypical psychosis and schizophrenia
22. Dosage and administration
23. Comparison of efficacy of lithium carbonate and chlor pro marine in mania by double‐blind controlled study
24. The biotransformation of carbamazepine
25. Carbama‐zepine‐induced reduction of blood levels of haloperidol in chronic schizophrenia
26. Effect of carbamazepine on plasma haloperidol levels
27. Does carbamaze‐pine‐induced reduction of plasma haloperidol levels worsen psychotic symptoms